Screening immunomodulatory Q‐markers in Astragali Radix based on UHPLC‐QTOF‐MS analysis and spectrum–effect relationship
Biomedical Chromatography · 2024
DOI: 10.1002/bmc.6015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Qin Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Lanzhou University, Lanzhou, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Astragalus propinquus, Cytokines, Saponins. Die Arbeit nennt 49 Literaturangaben. Gefördert von: the Key Project of NMPA Key Laboratory for Quality Control of Traditional Chinese Medicine, the Medical Innovation and development project of Lanzhou University, Gansu Provincial Science and Technology Plan Project.
Abstract (Originalsprache)
Astragali Radix (AR) is one of the famous traditional Chinese medicines (TCMs) for boosting immunity, whereas the quality markers (Q‐markers) of AR have not been clearly researched. The immunomodulatory activities of the bioactive extractions and components were evaluated by NO inhibition rate; phagocytic index; IL‐10, TNF‐α, IL‐1β, and IL‐6 cytokines in RAW264.7 cells; and the relative proliferation rate of spleen cells. The total saponins (TS) and the grade 2 ( Xiaoxuan , XX) of AR showed the strongest immunomodulatory activities. At the concentration of 40 μg/mL, the TS increased spleen cells proliferation by 48.0% and upregulated the level of IL‐1β and IL‐6. Cytokines in the XX‐treated group were at least 1.6 times higher than the control group. A total of 190 common peaks were detected in AR by ultrahigh‐performance liquid chromatography coupled with quadrupole‐time‐of‐flight mass spectrometry (UHPLC‐QTOF‐MS). The multivariate statistical analyses revealed that 41 compounds were positively correlated with immune responses, and bioactive compounds were verified by using RAW264.7 cell assay. Subsequently, the contents of six compounds in different commercial grades were determined, and the results showed the same trend in contents and activities. Finally, calycosin‐7‐ O ‐ β ‐D‐glucoside, astragaloside IV, astragaloside II, astragaloside I, isomucronulatol‐7‐ O ‐glucoside, and 9,10‐dimethoxypterocarpan‐3‐ O ‐glucoside were screened out as immunomodulatory Q‐markers of AR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Lanzhou University, Lanzhou, China.
- Gansu Institute of Drug Control, Lanzhou, China.
- Collaborative Innovation Center for Northwestern Chinese Medicine, Lanzhou University, Lanzhou, China.
- State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou, China.
Förderung
- the Key Project of NMPA Key Laboratory for Quality Control of Traditional Chinese Medicine
- the Medical Innovation and development project of Lanzhou University
- Gansu Provincial Science and Technology Plan Project
Zitieren
APA
Chen, Q., Chen, P., Bi, C., Shen, X., Guo, L., Jiang, Y., Liu, Y., Wu, Y., Li, Y., Wu, Z., Zhu, X., Song, P., Yang, P., Zhang, Y., & Yang, Z. (2024). Screening immunomodulatory Q‐markers in Astragali Radix based on UHPLC‐QTOF‐MS analysis and spectrum–effect relationship. Biomedical Chromatography. https://doi.org/10.1002/bmc.6015
Vancouver
Chen Q, Chen P, Bi C, Shen X, Guo L, Jiang Y, et al. Screening immunomodulatory Q‐markers in Astragali Radix based on UHPLC‐QTOF‐MS analysis and spectrum–effect relationship. Biomedical Chromatography. 2024. doi:10.1002/bmc.6015
BibTeX
@article{Chen2024,
author = {Chen, Qin and Chen, Ping and Bi, Chunmei and Shen, Xue and Guo, Lirong and Jiang, Yihan and Liu, Yanan and Wu, Yangyang and Li, Yimeng and Wu, Zhengrong and Zhu, Xujiang and Song, Pingshun and Yang, Pingrong and Zhang, Yawen and Yang, Zhigang},
title = {Screening immunomodulatory Q‐markers in Astragali Radix based on UHPLC‐QTOF‐MS analysis and spectrum–effect relationship},
journal = {Biomedical Chromatography},
year = {2024},
doi = {10.1002/bmc.6015}
}
EUVIMED